Source Post
Hims & Hers: Generational Buying Opportunity or a Falling Knife at $16? | HIMS Stock Analysis
Feb 13, 2026
The creator analyzes the recent crash in Hims & Hers stock following an FDA crackdown and a Novo Nordisk lawsuit. He highlights a significant expected deceleration in revenue growth as the company's weight loss business faces regulatory hurdles.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.